Opioid and Pain Management Best Practices: Strategies for Success: Self – Assessment

Prepared by IPRO QIN-QIO, Centers for Medicare & Medicaid Services Quality Improvement & Innovation Group

Use with Quality Improvement and Care Coordination: Implementing the CDC Guideline for Prescribing Opioids for Chronic Pain document and the Opioid and Pain Management Best Practice Aggregate Results Dashboard.

IPRO HQIC presents: The Impact of Meaningful Medication Reconciliation on ADEs, January 13, 2022

This material was prepared by The Bizzell Group (Bizzell), the Data Validation and Administrative (DVA) contractor, under contract with
the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS).

Hospital leaders from across the country attend the HQIC Community of Practice Call. The small, rural and critical access voice was amplified through sharing of barriers and best practices alike. Furthermore, subject matter experts shared their perspectives and their favorite resources. This resource contains a link to the Januray 13, 2021 video, presentation slides, and tools documentation.

HQIC Antibiotic Stewardship Workgroup: Penicillin Allergy Module

Developed by the Network of Quality Improvement and Innovation Contractors for the Centers of Medicare and Medicaid Services Quality Improvement and Innovation Group – QIN/QIO HQIC

This resource contains two video conversations on how to develop and maintain a successful penicillin allergy program, and how to initiate and sustain an antibiotic allergy clarification program. Additional resources include CDC fact sheet, allergy poster, and Evaluation and Diagnosis of Penicillin Allergy for Healthcare Professionals documentation.

Patient Safety & Behavioral Health: Antipsychotic Medication Adverse Drug Events (ADE’s)

This material was prepared by Alliant Quality, and adapted by the IPRO QIN-QIO, a collaboration of Healthcentric Advisors, Qlarant and IPRO, serving as the Medicare Quality Innovation Network-Quality Improvement Organization.

This resource discusses the common effects of antipsychotic ADE’s, and provides links to other resources and interventions that support the prevention of adverse events. Adverse drug events cause approximately 1.3 million emergency department visits each year. About 350,000 patients each year need to be hospitalized for further treatment after emergency visits for adverse drug events. People typically take more medicines as they age, and the risk of adverse events may increase as more people take more medicines.

National Healthcare Safety Network (NHSN)Patient Safety Analysis Resource

Centers for Disease Control and Prevention

The NHSN application provides various options that allow NHSN users to analyze their surveillance data. The resources listed on the link above are intended to help you use the analysis tool, and interpret data analyzed from the Patient Safety Component of NHSN.

Interactive Training Series: CDC Guidelines for Prescribing Opioids for Chronic Pain

Centers for Disease Control and Prevention (CDC)

This interactive, web-based training features self-paced learning, case-based content, knowledge checks, and integrated resources to help healthcare providers gain a deeper understanding of the CDC Guideline for Prescribing Opioids for Chronic Pain. Find tips on implementing the Guideline in primary care practice and overcoming challenges. Earn free CE.

Prescription Drug Monitoring Programs (PDMPs): Drug Overdose:

Center for Disease Control and Prevention (CDC)

Clinical practice guidelines encourage use of the PDMP prior to prescribing to assess a patient’s history of controlled substance use. It is possible to improve the way opioids are prescribed, reducing the number of people who misuse, abuse, or overdose from them, while making sure patients have access to safe, effective pain management. A prescription drug monitoring program (PDMP) is an electronic database that tracks controlled substance prescriptions. PDMPs can help identify patients who may be misusing prescription opioids or other prescription drugs and who may be at risk for overdose.

VTE & VTE/COVID-19 Resources

North American Thrombosis Forum (NATF)

The North American Thrombosis Forum is dedicated to saving lives through education and prevention. A major part of this is helping healthcare professionals stay up-to-date on the latest research in the rapidly changing field of thrombosis. Through educational events and informative articles geared specifically towards clinicians, NATF provides clinicians with the information they need to best treat their patients. Topics covered include thrombosis, stroke prevention, atrial fibrillation, diabetes, cardiovascular-related illnesses, and more. Check back regularly for important updates on everything from the development of new medications, to the release of novel research.

Managing the Risks of Direct Oral Anticoagulants

The Joint Commission: Sentinel Event Alert

While DOACs offer ease of use to patients, stopping bleeding events in patients on DOACs is more complicated, requiring different strategies than those for patients on warfarin (Coumadin®) and heparin. Unlike the more widely available reversal agents for warfarin and heparin, reversal agents for DOACs are lesser known and may not be available in every care setting. Also, some DOACs have no FDA-approved reversal agent at this time. Therefore, bleeding complications can be severe if these patients are not assessed according to guidelines on the management of DOACs. Intracranial hemorrhage is the most serious emergent bleeding risk.

In response to an increase in adverse events related to these widely prescribed medications, this alert provides guidance on the safe use and management of DOACs to all medical practitioners and health care organization leaders, particularly chief medical officers, pharmacists, emergency department clinicians, and quality and safety officers.